Liquid Lung DX, Inc.

FAIRFIELD, CT · Founded 2018 · CIK 0001771742 · Medtech · Private

Liquid biopsy diagnostic test for lung cancer detection and monitoring

liquidlung.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$70K
1 Form D · Mar 2019
90 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$70,002
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1234Anumana, Inc.—$32M
1235ETHOS RESEARCH AND DEVELOPMENT, LLC——
1236Scanadu Inc—$45M
1237Liquid Lung DX, Inc.—$70K
1238ADVANCED MEDICAL DEVICE TECHNOLOGIES, INC.——
1239DYNOCARDIA, INC.—$2.9M
1240ACTUS INTERACTIVE SOFTWARE LLC—$243K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Martin KeiserDirector · Executive Officer
  • Martin Keiser, Jr.Director
  • Patrick LilleyDirector
  • Sean MiotDirector
  • Steven Van FleetDirector

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.